Good Morning America
on May 20 featured Dr. Marco Costa
, a leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University Hospitals, Case Western Reserve University
, using the newest imaging technology available to hospitals in the United States
-- Optical Coherence Tomography.
Dr. Costa is featured performing one of the first procedures in the United States with the new C7-XR™ FD-OCT™ Imaging System from LightLabs Imaging, and its companion C7 Dragonfly™ Imaging Catheter, following its FDA clearance. The images from this system enabled Dr. Costa to study features of his patient's arterial disease, which provided critical information for his decisions regarding stent size and placement that would not have been possible with other previously available imaging modalities. The procedure was completed successfully and the patient is doing well.
LightLab was in the news earlier this weed with the announcement of the company's sale to St. Jude Medical, Inc., a global medical device company, for approximately $90 million.
During the second half of 2010, St. Jude Medical expects the OCT platform to contribute an additional $20 million in revenue to its cardiovascular business. The OCT market is expected to grow at a double-digit compounded annual rate over the next five years and is expected to capture intravascular ultrasound imaging systems (IVUS) market share as well as expand the market for coronary imaging. The IVUS market is estimated to be $500 million for 2010, and is growing 10 to 15 percent annually. OCT coronary imaging is expected to grow at an even faster rate within this market.
Cutting Edge Medicine: New Look Inside the Heart (Good Morning America)
LightLab Imaging selling to St. Jude Medical (Mass High Tech)